# EDGAR Filing Document

**Accession Number:** 0001559109
**File Stem:** 0001752724-25-156491
**Filing Date:** 2025-6
**Character Count:** 24392
**Document Hash:** 4664dcaa63ad7c94134bd979cbfabffe
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-156491.hdr.sgml**: 20250625

**ACCESSION NUMBER**: 0001752724-25-156491

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250430

**FILED AS OF DATE**: 20250625

**DATE AS OF CHANGE**: 20250625

**PERIOD START**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ETFis Series Trust I
- **CENTRAL INDEX KEY:** 0001559109

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22819
- **FILM NUMBER:** 251073896

**BUSINESS ADDRESS:**
- **STREET 1:** 31 WEST 52ND STREET
- **STREET 2:** 16TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 2125934383

**MAIL ADDRESS:**
- **STREET 1:** 31 WEST 52ND STREET
- **STREET 2:** 16TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ETF Actively Managed Trust
- **DATE OF NAME CHANGE:** 20120926

## Series and Classes Contracts Data

### Virtus LifeSci Biotech Products ETF (Series ID: S000047354)

| Class ID   | Class Name                          | Ticker Symbol   |
|:---|:---|:---|
| C000148682 | Virtus LifeSci Biotech Products ETF | BBP             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** ETFis Series Trust I

- **b. Investment Company Act file number:** 811-22819

- **c. CIK number of Registrant:** 0001559109

- **d. LEI of Registrant:** 5493002CWTVLBPSYFT98

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 31 West 52nd Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10019

  - **Telephone number:** 347-903-7347

**Item A.2. Information about the Series.**

- **a. Name of Series:** Virtus LifeSci Biotech Products ETF

- **b. EDGAR series identifier (if any):** S000047354

- **c. LEI of Series:** 549300U4V8YBNY7O1032

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-10-31

- **b. Date as of which information is reported:** 2025-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $24030863.08

**Total Liabilities:** $424680.85

**Net Assets:** $23606182.23

**Cash Not Reported:** $92331.86

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000148682 | -0.10%               | -5.83%               | 0.73%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $0.00                    | $-12988.30                                 |
| Month 2  | $426447.53               | $-1687244.80                               |
| Month 3  | $0.00                    | $351921.27                                 |

### Schedule of Portfolio Investments

| Name                           | Title                                     | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Insmed Inc                     | Insmed Inc                                | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |      5702 | NS      | $410544.00    | 1.74%             |  |  |  | No            |                  1 | On Loan: No      |
| HALOZYME THERAPEUTICS INC      | HALOZYME THERAPEUTICS INC                 | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |      8582 | NS      | $527106.44    | 2.23%             |  |  |  | No            |                  1 | On Loan: No      |
| BIOMARIN PHARMACEUTICAL INC    | BIOMARIN PHARMACEUTICAL INC               | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |      6193 | NS      | $394432.17    | 1.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S            | Ascendis Pharma A/S                       | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |      3141 | NS      | $535352.04    | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |
| INCYTE CORP                    | INCYTE CORP                               | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |      5800 | NS      | $363428.00    | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| NEUROCRINE BIOSCIENCES INC     | NEUROCRINE BIOSCIENCES INC                | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |      3240 | NS      | $348915.60    | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| ULTRAGENYX PHARMACEUTICAL IN   | ULTRAGENYX PHARMACEUTICAL INC             | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |      8754 | NS      | $341230.92    | 1.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd           | Roivant Sciences Ltd                      | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | US        |     34556 | NS      | $401540.72    | 1.70%             |  |  |  | No            |                  1 | On Loan: —       |
| Madrigal Pharmaceuticals Inc   | Madrigal Pharmaceuticals Inc              | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |      1358 | NS      | $453449.78    | 1.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Phathom Pharmaceuticals Inc    | Phathom Pharmaceuticals Inc               | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51417 | NS      | $220578.93    | 0.93%             |  |  |  | No            |                  1 | On Loan: —       |
| Geron Corp                     | Geron Corp                                | CUSIP: 374163103<br>LEI: 549300T282D7Z2YESL90 | Long             | EC               | CORP              | US        |    104731 | NS      | $147670.71    | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG         | CRISPR Therapeutics AG                    | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |      9039 | NS      | $349538.13    | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| IONIS PHARMACEUTICALS INC      | IONIS PHARMACEUTICALS INC                 | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |     11093 | NS      | $340666.03    | 1.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Y-mAbs Therapeutics Inc        | Y-mAbs Therapeutics Inc                   | CUSIP: 984241109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     42025 | NS      | $178606.25    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Legend Biotech Corp            | Legend Biotech Corp                       | CUSIP: 52490G102<br>LEI: 254900EIUFZTW136H859 | Long             | EC               | CORP              | US        |     11568 | NS      | $404301.60    | 1.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Zai Lab Ltd                    | Zai Lab Ltd                               | CUSIP: 98887Q104<br>LEI: 549300P2UYQ9U5LY1T58 | Long             | EC               | CORP              | CN        |     15363 | NS      | $486853.47    | 2.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Sage Therapeutics Inc          | Sage Therapeutics Inc                     | CUSIP: 78667J108<br>LEI: 5493000JX4BJS9W6CN35 | Long             | EC               | CORP              | US        |     72408 | NS      | $527854.32    | 2.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Esperion Therapeutics Inc      | Esperion Therapeutics Inc                 | CUSIP: 29664W105<br>LEI: 549300OFU56UKEWVUS92 | Long             | EC               | CORP              | US        |    161007 | NS      | $160910.40    | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc       | Travere Therapeutics Inc                  | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22923 | NS      | $477027.63    | 2.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc    | Apellis Pharmaceuticals Inc               | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |     12541 | NS      | $240912.61    | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc     | Tarsus Pharmaceuticals Inc                | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8033 | NS      | $416993.03    | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb, Inc.                   | OmniAb, Inc.                              | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1295 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Day One Biopharmaceuticals Inc | Day One Biopharmaceuticals Inc            | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     32053 | NS      | $249372.34    | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| ImmunityBio Inc                | ImmunityBio Inc                           | CUSIP: 45256X103<br>LEI: 529900J9XLBR4HFL4B83 | Long             | EC               | CORP              | US        |    135049 | NS      | $338972.99    | 1.44%             |  |  |  | No            |                  1 | On Loan: —       |
| SpringWorks Therapeutics Inc   | SpringWorks Therapeutics Inc              | CUSIP: 85205L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10611 | NS      | $491289.30    | 2.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunocore Holdings PLC        | Immunocore Holdings PLC                   | CUSIP: 45258D105<br>LEI: 213800IUE3DFS84BVN18 | Long             | EC               | CORP              | GB        |     13547 | NS      | $407764.70    | 1.73%             |  |  |  | No            |                  1 | On Loan: —       |
| ADMA Biologics Inc             | ADMA Biologics Inc                        | CUSIP: 000899104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21990 | NS      | $523362.00    | 2.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Iovance Biotherapeutics Inc    | Iovance Biotherapeutics Inc               | CUSIP: 462260100<br>LEI: 2549002L8WT2ACU5Q878 | Long             | EC               | CORP              | US        |     51580 | NS      | $185172.20    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| VERTEX PHARMACEUTICALS INC     | VERTEX PHARMACEUTICALS INC                | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |       884 | NS      | $450398.00    | 1.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Lexicon Pharmaceuticals Inc    | Lexicon Pharmaceuticals Inc               | CUSIP: 528872302<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    499341 | NS      | $364918.40    | 1.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Dynavax Technologies Corp      | Dynavax Technologies Corp                 | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |     31602 | NS      | $371323.50    | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| GILEAD SCIENCES INC            | GILEAD SCIENCES INC                       | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      4483 | NS      | $477618.82    | 2.02%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                    | BioNTech SE                               | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |      3403 | NS      | $354422.45    | 1.50%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics Inc           | PTC Therapeutics Inc                      | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |      8671 | NS      | $432162.64    | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENERON PHARMACEUTICALS      | REGENERON PHARMACEUTICALS INC             | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       556 | NS      | $332910.56    | 1.41%             |  |  |  | No            |                  1 | On Loan: No      |
| BioCryst Pharmaceuticals Inc   | BioCryst Pharmaceuticals Inc              | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |     54018 | NS      | $478059.30    | 2.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Blueprint Medicines Corp       | Blueprint Medicines Corp                  | CUSIP: 09627Y109<br>LEI: 5299004CC60O9T5HVM83 | Long             | EC               | CORP              | US        |      4435 | NS      | $396932.50    | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| EXELIXIS INC                   | EXELIXIS INC                              | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |     11674 | NS      | $457037.10    | 1.94%             |  |  |  | No            |                  1 | On Loan: No      |
| DREYFUS GOVERNMENT CASH MANAGE | DREYFUS GOVERNMENT CASH MANAGE            | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    412100 | NS      | $412099.54    | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Aurinia Pharmaceuticals Inc    | Aurinia Pharmaceuticals Inc               | CUSIP: 05156V102<br>LEI: 5299008YP2BW4570ML28 | Long             | EC               | CORP              | CA        |     42368 | NS      | $349112.32    | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Kiniksa Pharmaceuticals Intern | Kiniksa Pharmaceuticals International Plc | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20387 | NS      | $549837.39    | 2.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                      | Amgen Inc                                 | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |      1497 | NS      | $435507.24    | 1.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc    | Alnylam Pharmaceuticals Inc               | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |      1678 | NS      | $441716.72    | 1.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc           | Bridgebio Pharma Inc                      | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |     14841 | NS      | $569300.76    | 2.41%             |  |  |  | No            |                  1 | On Loan: —       |
| Rhythm Pharmaceuticals Inc     | Rhythm Pharmaceuticals Inc                | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |      7371 | NS      | $480515.49    | 2.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                    | Moderna Inc                               | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |      9588 | NS      | $273641.52    | 1.16%             |  |  |  | No            |                  1 | On Loan: No      |
| ACADIA Pharmaceuticals Inc     | ACADIA Pharmaceuticals Inc                | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |     23790 | NS      | $347334.00    | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Harmony Biosciences Holdings I | Harmony Biosciences Holdings Inc          | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12885 | NS      | $379720.95    | 1.61%             |  |  |  | No            |                  1 | On Loan: —       |
| THERAVANCE BIOPHARMA INC       | THERAVANCE BIOPHARMA INC                  | CUSIP: 000000000<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |     41600 | NS      | $406432.00    | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| TG Therapeutics Inc            | TG Therapeutics Inc                       | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |     13376 | NS      | $608741.76    | 2.58%             |  |  |  | No            |                  1 | On Loan: —       |
| Ardelyx Inc                    | Ardelyx Inc                               | CUSIP: 039697107<br>LEI: 549300F542QR4SXHCY32 | Long             | EC               | CORP              | US        |     78348 | NS      | $431305.74    | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| BIOGEN INC                     | BIOGEN INC                                | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |      2643 | NS      | $320014.44    | 1.36%             |  |  |  | No            |                  1 | On Loan: No      |
| IRONWOOD PHARMACEUTICALS INC   | IRONWOOD PHARMACEUTICALS INC              | CUSIP: 46333X108<br>LEI: 549300PC8MR6QHH6P296 | Long             | EC               | CORP              | US        |    115325 | NS      | $107517.50    | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| UNITED THERAPEUTICS CORP       | UNITED THERAPEUTICS CORP                  | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      1137 | NS      | $344613.33    | 1.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Amicus Therapeutics Inc        | Amicus Therapeutics Inc                   | CUSIP: 03152W109<br>LEI: 549300MRD1SMUTNBPQ53 | Long             | EC               | CORP              | US        |     40446 | NS      | $310625.28    | 1.32%             |  |  |  | No            |                  1 | On Loan: No      |
| AGIOS PHARMACEUTICALS INC      | AGIOS PHARMACEUTICALS INC                 | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |     10758 | NS      | $319405.02    | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| BeiGene Ltd                    | BeiGene Ltd                               | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | US        |      2274 | NS      | $590807.94    | 2.50%             |  |  |  | No            |                  1 | On Loan: No      |
| LIGAND PHARMACEUTICALS         | LIGAND PHARMACEUTICALS INC                | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |      3616 | NS      | $397253.76    | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb, Inc.                   | OmniAb, Inc.                              | CUSIP: 68218J202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1295 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Krystal Biotech Inc            | Krystal Biotech Inc                       | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |      2365 | NS      | $401766.20    | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| SAREPTA THERAPEUTICS INC       | SAREPTA THERAPEUTICS INC                  | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |      3297 | NS      | $205732.80    | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirum Pharmaceuticals Inc      | Mirum Pharmaceuticals Inc                 | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |      9711 | NS      | $421942.95    | 1.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Novavax Inc                    | Novavax Inc                               | CUSIP: 670002401<br>LEI: 529900J4GJHPEPQ23205 | Long             | EC               | CORP              | US        |     45518 | NS      | $303605.06    | 1.29%             |  |  |  | No            |                  1 | On Loan: —       |
| Axsome Therapeutics Inc        | Axsome Therapeutics Inc                   | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |      4352 | NS      | $488686.08    | 2.07%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-06-23

**Name of Applicant:** ETFis Series Trust I

**Signature:** Brinton W. Frith

**Name of Signer:** Brinton W. Frith

**Title:** Treasurer and Principal Financial Officer